Gene expression profiling of human liver cancer cells following celecoxib tretment

Altered gene expression profiles in liver cancer cells upon sorafenib treatment

Antitumor activity of the novel small molecule Akt inhibitor SC66 in hepatocellular carcinoma cells.

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide characterized by poor and often limited or no response to current drug therapies. The PI3K/Akt/mTOR pathway is a key regulator of cell proliferation and survival. Alterations in this pathway have been reported in many types of human cancer, including HCC. It has become evident that Akt inhibitors have great potential in cancer treatment. SC66 is a new allosteric Akt inhibitor that facilitates ubiquitination of Akt, favoring its degradation via the proteasome, thus inhibiting Akt signaling. In the present study, we investigated the anticancer activity of SC66 in HCC cell lines (HepG2, Huh7, Hep3B, PLC/PRF/5 and HA22T/VG…

Contagious agalactiae: a preliminary study on its impact on milk production of Sicilian sheep

Un'analisi controfattuale degli incentivi agli investimenti infrastrutturali per lo sviluppo locale: il caso dei PIT